Not applicableStudy completedNCT02441166What this trial is testingDiagnostic Value of Bone Marrow Tryptase in Systemic MastocytosisWho this might be right forSystemic Mastocytosis University Hospital, Toulouse 250
Testing effectiveness (Phase 2)Study completedNCT00154388What this trial is testingPhase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesWho this might be right forLife Threatening Diseases Novartis Pharmaceuticals 185
Early research (Phase 1)Looking for participantsNCT05362773What this trial is testingMGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesWho this might be right forLeukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more MacroGenics 130
Early research (Phase 1)Ended earlyNCT05609942What this trial is testingStudy of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic MalignanciesWho this might be right forAdvanced Systemic Mastocytosis Blueprint Medicines Corporation 9
Very early researchStudy completedNCT00424242What this trial is testingPemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Northwestern University 15
Not applicableWithdrawnNCT00499668What this trial is testingAprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+5 more Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00132015What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Institutes of Health Clinical Center (CC) 37
Not applicableStudy completedNCT00996047What this trial is testingS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 3,341
Not applicableLooking for participantsNCT01137643What this trial is testingTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more UNC Lineberger Comprehensive Cancer Center 15,000
Large-scale testing (Phase 3)Study completedNCT00814073What this trial is testingMasitinib in Severe Indolent or Smoldering Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis AB Science 135
Testing effectiveness (Phase 2)Study completedNCT00171912What this trial is testingImatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesWho this might be right forHypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more Novartis Pharmaceuticals 38
Not applicableEnded earlyNCT00899951What this trial is testingStudying Fentanyl in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)Study completedNCT01273766What this trial is testingDeferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesWho this might be right forAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more Wake Forest University Health Sciences 16
Not applicableStudy completedNCT00001356What this trial is testingCharacteristics of Mast Cells in MastocytosisWho this might be right forMastocytosis National Institute of Allergy and Infectious Diseases (NIAID) 300
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT03779854What this trial is testingNaive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell TransplantWho this might be right forAcute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+14 more Fred Hutchinson Cancer Center 68
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Not applicableStudy completedNCT00112593What this trial is testingFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more Fred Hutchinson Cancer Center 5
Testing effectiveness (Phase 2)WithdrawnNCT03739606What this trial is testingFlotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWho this might be right forAcute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT00666211What this trial is testingOpioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Vanderbilt-Ingram Cancer Center 98